Here's some news that was only a matter of time: The world's largest and most well-known Artificial Intelligence company, OpenAI, is partnering with a biotech company to figure out how to extend human life. 

Cue the science fiction movie soundtrack.

OpenAI is working with Retro Biosciences to “re-engineer proteins that can turn human skin cells into young-seeming stem cells. Retro believes these proteins are a promising step toward building human organs and providing supplies of replacement cells.”

I guess we're just about in the “AI is a matter of life or death” phase of its development.